ORIC (Oric Pharmaceuticals, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by ORIC officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-28 | Dominic Piscitelli | Chief Financial Officer | MIXED | — | — |
| 2026-07-28 | Richard A. Heyman | Director | MIXED | — | — |
| 2026-07-08 | Richard A. Heyman | Director | Sell | — | — |
| 2026-02-26 | Dominic Piscitelli | Chief Financial Officer | MIXED | — | — |
| 2026-01-20 | Richard A. Heyman | Director | Sell | — | — |
| 2026-01-06 | Jacob Chacko | PRESIDENT AND CEO | A | — | — |
| 2026-01-06 | Steven L. Hoerter | Director | A | — | — |
| 2026-01-06 | Richard A. Heyman | Director | A | — | — |
| 2026-01-06 | Lori Anne Kunkel | Director | A | — | — |
| 2026-01-06 | Pratik S Multani | Chief Medical Officer | A | — | — |
| 2026-01-06 | Dominic Piscitelli | Chief Financial Officer | A | — | — |
| 2026-01-06 | Angie You | Director | A | — | — |
| 2026-01-06 | Mardi Dier | Director | A | — | — |
| 2025-12-17 | Dominic Piscitelli | Chief Financial Officer | MIXED | — | — |
| 2025-12-17 | Jacob Chacko | PRESIDENT AND CEO | MIXED | — | — |
| 2025-12-17 | Pratik S Multani | Chief Medical Officer | MIXED | — | — |
| 2025-12-09 | Lori Anne Kunkel | Director | M | — | — |
| 2025-12-05 | Lori Anne Kunkel | Director | M | — | — |
| 2025-10-08 | Jacob Chacko | PRESIDENT AND CEO | Sell | — | — |
| 2025-10-08 | Dominic Piscitelli | Chief Financial Officer | MIXED | — | — |
| 2025-10-03 | Richard A. Heyman | Director | M | — | — |
| 2025-10-02 | Jacob Chacko | PRESIDENT AND CEO | Sell | — | — |
| 2025-09-24 | Jacob Chacko | PRESIDENT AND CEO | Sell | — | — |
| 2025-07-02 | Dominic Piscitelli | Chief Financial Officer | Sell | — | — |
| 2025-06-24 | Dominic Piscitelli | Chief Financial Officer | Sell | — | — |
| 2025-06-23 | Angie You | Director | Buy | — | — |
| 2025-06-13 | Dominic Piscitelli | Chief Financial Officer | Sell | — | — |
| 2025-06-11 | Dominic Piscitelli | Chief Financial Officer | Sell | — | — |
| 2025-06-09 | Dominic Piscitelli | Chief Financial Officer | Sell | — | — |
| 2025-03-04 | Lori Anne Kunkel | Director | M | — | — |
| 2025-01-06 | Lori Anne Kunkel | Director | A | — | — |
| 2025-01-06 | Angie You | Director | A | — | — |
| 2025-01-06 | Steven L. Hoerter | Director | A | — | — |
| 2025-01-06 | Mardi Dier | Director | A | — | — |
| 2025-01-06 | Richard A. Heyman | Director | A | — | — |
| 2025-01-03 | Jacob Chacko | PRESIDENT AND CEO | A | — | — |
| 2025-01-03 | Pratik S Multani | Chief Medical Officer | A | — | — |
| 2025-01-03 | Dominic Piscitelli | Chief Financial Officer | A | — | — |
| 2024-12-17 | Dominic Piscitelli | Chief Financial Officer | MIXED | — | — |
| 2024-12-17 | Pratik S Multani | Chief Medical Officer | MIXED | — | — |
| 2024-12-17 | Jacob Chacko | PRESIDENT AND CEO | MIXED | — | — |
| 2024-06-14 | Richard A. Heyman | Director | A | — | — |
| 2024-06-14 | Angie You | Director | A | — | — |
| 2024-06-14 | Lori Anne Kunkel | Director | A | — | — |
| 2024-06-14 | Mardi Dier | Director | A | — | — |
| 2024-06-14 | Steven L. Hoerter | Director | A | — | — |
| 2024-06-04 | Lori Anne Kunkel | Director | M | — | — |
| 2024-03-08 | Jacob Chacko | PRESIDENT AND CEO | Sell | — | — |
| 2024-02-08 | Jacob Chacko | PRESIDENT AND CEO | Sell | — | — |
| 2024-01-03 | Dominic Piscitelli | Chief Financial Officer | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 4,616,666 | — |
| — | Director | 4,616,666 | — |
| — | 10%+ Owner | 3,855,883 | — |
| — | 10%+ Owner | 2,500,000 | — |
| — | Director | 2,395,334 | — |
| — | Director | 2,240,440 | — |
| — | Director | 2,212,571 | — |
| — | 10%+ Owner | 1,100,446 | — |
| — | PRESIDENT AND CEO | 581,711 | — |
| — | Director | 251,972 | — |
| — | Director | 84,200 | — |
| — | Chief Financial Officer | 69,828 | — |
| — | Chief Medical Officer | 68,149 | — |
| — | Director | 40,423 | — |
| — | Director | 26,597 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ORIC quote page; the site-wide leaderboard is on the insider transactions hub.